Clinical Trial Update: Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety

View source ↗

Summary

A completed clinical trial update assessing patient characteristics of intermediate-stage hepatocellular carcinoma patients treated with sorafenib (Nexavar), in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Status: COMPLETED